MBD3 Localizes at Promoters, Gene Bodies and Enhancers of Active Genes

The Mi-2/nucleosome remodeling and histone deacetylase (NuRD) complex is a multiprotein machine proposed to regulate chromatin structure by nucleosome remodeling and histone deacetylation activities. Recent reports describing localization of NuRD provide new insights that question previous models on NuRD action, but are not in complete agreement. Here, we provide location analysis of endogenous MBD3, a component of NuRD complex, in two human breast cancer cell lines (MCF-7 and MDA-MB-231) using two independent genomic techniques: DNA adenine methyltransferase identification (DamID) and ChIP-seq. We observed concordance of the resulting genomic localization, suggesting that these studies are converging on a robust map for NuRD in the cancer cell genome. MBD3 preferentially associated with CpG rich promoters marked by H3K4me3 and showed cell-type specific localization across gene bodies, peaking around the transcription start site. A subset of sites bound by MBD3 was enriched in H3K27ac and was in physical proximity to promoters in three-dimensional space, suggesting function as enhancers. MBD3 enrichment was also noted at promoters modified by H3K27me3. Functional analysis of chromatin indicated that MBD3 regulates nucleosome occupancy near promoters and in gene bodies. These data suggest that MBD3, and by extension the NuRD complex, may have multiple roles in fine tuning expression for both active and silent genes, representing an important step in defining regulatory mechanisms by which NuRD complex controls chromatin structure and modification status.

[1]  R. Chalkley,et al.  Studies on highly metabolically active acetylation and phosphorylation of histones. , 1975, The Journal of biological chemistry.

[2]  M. Wand.  Data-Based Choice of Histogram Bin Width , 1997 .

[3]  A. Bird,et al.  Identification and Characterization of a Family of Mammalian Methyl-CpG Binding Proteins , 1998, Molecular and Cellular Biology.

[4]  J. T. Kadonaga,et al.  The “Dark Side” of Chromatin Remodeling Repressive Effects on Transcription , 1999, Cell.

[5]  S. Henikoff,et al.  Identification of in vivo DNA targets of chromatin proteins using tethered Dam methyltransferase , 2000, Nature Biotechnology.

[6]  P. Wade,et al.  Methyl CpG binding proteins: coupling chromatin architecture to gene regulation , 2001, Oncogene.

[7]  Cameron S. Osborne,et al.  Long-range chromatin regulatory interactions in vivo , 2002, Nature Genetics.

[8]  J. Dekker,et al.  Capturing Chromosome Conformation , 2002, Science.

[9]  D. Reinberg,et al.  Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. , 2002, Genes & development.

[10]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[11]  Tony Kouzarides,et al.  Histone H3 Lysine 4 Methylation Disrupts Binding of Nucleosome Remodeling and Deacetylase (NuRD) Repressor Complex* , 2002, The Journal of Biological Chemistry.

[12]  Carlos S. Moreno,et al.  MTA3, a Mi-2/NuRD Complex Subunit, Regulates an Invasive Growth Pathway in Breast Cancer , 2003, Cell.

[13]  J. Seavitt,et al.  The chromatin remodeler Mi-2beta is required for CD4 expression and T cell development. , 2004, Immunity.

[14]  P. Wade,et al.  Use of bifunctional cross-linking reagents in mapping genomic distribution of chromatin remodeling complexes. , 2004, Methods.

[15]  Naoyuki Fujita,et al.  Mi-2/NuRD: multiple complexes for many purposes. , 2004, Biochimica et biophysica acta.

[16]  W. Lam,et al.  Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells , 2005, Nature Genetics.

[17]  B. van Steensel,et al.  DamID: mapping of in vivo protein-genome interactions using tethered DNA adenine methyltransferase. , 2006, Methods in enzymology.

[18]  Mark Bieda,et al.  Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. , 2006, Genome research.

[19]  Hendrik G. Stunnenberg,et al.  MBD2/NuRD and MBD3/NuRD, Two Distinct Complexes with Different Biochemical and Functional Properties , 2006, Molecular and Cellular Biology.

[20]  Sean Davis,et al.  Statistics for ChIP-chip and DNase hypersensitivity experiments on NimbleGen arrays. , 2006, Methods in enzymology.

[21]  F. Bertucci,et al.  Gene expression profiling of breast cell lines identifies potential new basal markers , 2006, Oncogene.

[22]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[23]  Michael B. Stadler,et al.  Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome , 2007, Nature Genetics.

[24]  Jiangwen Zhang,et al.  The role of the chromatin remodeler Mi-2beta in hematopoietic stem cell self-renewal and multilineage differentiation. , 2008, Genes & development.

[25]  D. Khaitan,et al.  Role of KCNMA1 gene in breast cancer invasion and metastasis to brain , 2009, BMC Cancer.

[26]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[27]  Binding of the CHD4 PHD2 finger to histone H3 is modulated by covalent modifications. , 2009, The Biochemical journal.

[28]  Chen Zeng,et al.  A clustering approach for identification of enriched domains from histone modification ChIP-Seq data , 2009, Bioinform..

[29]  Dustin E. Schones,et al.  Genome-wide Mapping of HATs and HDACs Reveals Distinct Functions in Active and Inactive Genes , 2009, Cell.

[30]  Aaron R. Quinlan,et al.  Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features , 2022 .

[31]  Ruchir R. Shah,et al.  DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas , 2010, The Journal of experimental medicine.

[32]  Poshen B. Chen,et al.  Mbd3/NURD Complex Regulates Expression of 5-Hydroxymethylcytosine Marked Genes in Embryonic Stem Cells , 2011, Cell.

[33]  Timothy J. Durham,et al.  Combinatorial Patterning of Chromatin Regulators Uncovered by Genome-wide Location Analysis in Human Cells , 2011, Cell.

[34]  Raymond K. Auerbach,et al.  A User's Guide to the Encyclopedia of DNA Elements (ENCODE) , 2011, PLoS biology.

[35]  Wing-Kin Sung,et al.  ChIA-PET analysis of transcriptional chromatin interactions. , 2012, Methods.

[36]  Paul Bertone,et al.  NuRD Suppresses Pluripotency Gene Expression to Promote Transcriptional Heterogeneity and Lineage Commitment , 2012, Cell stem cell.

[37]  G. Hu,et al.  NuRD and pluripotency: a complex balancing act. , 2012, Cell stem cell.

[38]  Zhaoyu Li,et al.  Foxa2 and H2A.Z Mediate Nucleosome Depletion during Embryonic Stem Cell Differentiation , 2012, Cell.

[39]  Paul Bertone,et al.  NuRD-mediated deacetylation of H3K27 facilitates recruitment of Polycomb Repressive Complex 2 to direct gene repression , 2011, The EMBO journal.

[40]  J. Seavitt,et al.  Harnessing of the Nucleosome Remodeling Deacetylase complex controls lymphocyte development and prevents leukemogenesis , 2011, Nature Immunology.

[41]  Eric S. Lander,et al.  Chromatin modifying enzymes as modulators of reprogramming , 2012, Nature.

[42]  Sharon Y. R. Dent,et al.  Histone-modifying enzymes: regulators of developmental decisions and drivers of human disease. , 2012, Epigenomics.

[43]  David A. Orlando,et al.  Enhancer decommissioning by LSD1 during embryonic stem cell differentiation , 2012, Nature.

[44]  Dennis C. Sgroi,et al.  Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes , 2016 .

[45]  Joel P Mackay,et al.  Bivalent recognition of nucleosomes by the tandem PHD fingers of the CHD4 ATPase is required for CHD4-mediated repression , 2012, Proceedings of the National Academy of Sciences.

[46]  Xiaodong Cheng,et al.  Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation , 2012, Nucleic acids research.

[47]  Q. Tao,et al.  Chromatin regulators with tumor suppressor properties and their alterations in human cancers. , 2012, Epigenomics.

[48]  M. Scharfe,et al.  Differential roles for MBD2 and MBD3 at methylated CpG islands, active promoters and binding to exon sequences , 2013, Nucleic acids research.

[49]  A. H. Smits,et al.  Dynamic Readers for 5-(Hydroxy)Methylcytosine and Its Oxidized Derivatives , 2013, Cell.

[50]  F. Lienert,et al.  Methylation-Dependent and -Independent Genomic Targeting Principles of the MBD Protein Family , 2013, Cell.

[51]  David A. Orlando,et al.  Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes , 2013, Cell.

[52]  T. Boggon,et al.  Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma , 2013, Proceedings of the National Academy of Sciences.

[53]  R. Tibshirani,et al.  Generalized Additive Models , 1986 .